Local

Doctor warns GLP-1 users about rare vision risk that may be permanent

FILE PHOTO: (Zarina Lukash/Getty Images/iStockphoto)

ATLANTA — As GLP-1 drugs continue to grow in popularity for weight loss and other conditions, there are new concerns about rare cases of vision loss and compounded versions of the medications sold online.

Dr. Joe Galati tells WSB there are new concerns about a possible link between GLP-1 medications and serious vision problems.

“The condition that we’re really talking about causes a relatively sudden, painless, loss of vision and it can be permanent,” Galati said.

The cases of vision loss are extremely rare. Gastrointestinal issues, fatigue and injection-site reactions are more commonly reported among users.

Galati recommends patients get a detailed eye examination before beginning a GLP-1 medication.

“If you are going to start one of these GLP-1 drugs for any reason, you should first get a detailed eye examination by your eye doctor to make sure there are no sorts of silent problems in your retina before you get started,” Galati said.

He said one of the concerns surrounding the vision loss is that it may not improve after a patient stops taking the medication.

“One of the problems is that this appears to be permanent loss, and so it’s not so much that you’re starting to have visual problems, you get off it and things get better; that’s why it’s so catastrophic that once this develops this can be permanent and there’s no going back,” Galati said.

Galati also warns about compounded GLP-1 medications sold online and recommends using FDA-approved drugs.

“The truth is you just do not know what you’re getting from a purity standpoint, from a dose standpoint,” Galati said.

An estimated 5 million Americans currently use compounded GLP-1 medications, mainly because of their lower prices. Galati said medications obtained through mail orders can create additional uncertainty.

“The things that we’re getting by mail, mail orders, they’re coming from China, you just don’t know what on Earth you’re getting which is going to increase the potential risk here and make it all the more confusing,” Galati said.

More than 10% of American adults are now estimated to use products such as Ozempic, Wegovy or Mounjaro for weight loss or chronic conditions.

Americans spent more than $70 billion on the drugs in 2023, up from an estimated $13.5 billion in 2018. Analysts believe current annual spending could surpass $130 billion.

Despite the concerns, Galati said the benefits of the medications continue to outweigh the potential risks.

“The benefits of these medications thus far outweigh the potential smaller risks for these many times devastating complications,” Galati said.

WSB Radio’s Ashley Simmons & Sabrina Cupit contributed to this story.